SK Biopharmaceuticals Expands Radiopharma Portfolio with New WARF In-Licensing
SK Biopharmaceuticals has in-licensed a second radiopharmaceutical therapy candidate from the Wisconsin Alumni Research Foundation (WARF), further strengthening its pipeline and advancing its strategy to build an integrated, globally competitive radiotherapeutics portfolio.
SK Biopharmaceuticals | 29/11/2025 | By Dineshwori | 141
Korean biotech company SK Biopharmaceuticals and Brazil-based Eurofarma have established a joint venture, Mentis Care, in Canada to commercialise an AI-powered epilepsy management platform. The new company marks SK Biopharmaceuticals’ full-scale expansion into digital healthcare beyond its innovative drug development portfolio.
SK Biopharmaceuticals | 21/10/2025 | By Dineshwori | 272
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy